Name | ATPγS tetralithium salt,Adenosine-5'-(γ-thio)-triphosphatetetralithiumsalt |
---|---|
Synonyms |
Tetralithium 5'-O-[({[(dioxidophosphorothioyl)oxy]phosphinato}oxy)phosphinato]adenosine
Adenosine, 5'-O-[hydroxy[[hydroxy[(hydroxymercaptophosphinyl)oxy]phosphinyl]oxy]phosphinyl]-, lithium salt (1:4) |
Description | ATPγS (tetralithium salt) is a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A[1]. |
---|---|
Related Catalog | |
In Vitro | ATPγS (tetralithium salt) enhances intrinsic fluorescence and induces aggregation which increases the activity of spinach Rubisco activase[1]. ATPγS (50-100 μM final blood concentration) attenuates inflammatory response with decreased accumulation of cells (48%, P < 0.01) and proteins (57%, P < 0.01) in bronchoalveolar lavage and reduces neutrophil infiltration and extravasation of Evans blue albumin dye into lung tissue[3]. |
In Vivo | ATPγS (tetralithium salt, 50 μM final, intravenous) demonstrates preserved lung parenchymal architecture[3]. ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice[3]. |
References |
Boiling Point | 940.5ºC at 760 mmHg |
---|---|
Molecular Formula | C10H12Li4N5O12P3S |
Molecular Weight | 546.979 |
Flash Point | 522.6ºC |
Exact Mass | 547.005615 |
PSA | 334.90000 |
LogP | 1.47200 |